Some epigenetic studies have shown that VDR is overexpressed in colorectal, prostate, and ovarian cancers, and increased VDR expression on tumor cells may be associated with a more favorable response to treatment [47,48,49,50,51]. The gene discussed is VDR; the disease is ovarian cancer.